Saturday 17 October 2026 Export PBYI’s income statement to Excel — free account

Puma Biotechnology, Inc.

Puma Biotechnology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $228.4 million, down 0.91% from fiscal 2024. In the quarter to June 2026, revenue grew 7.75%, EPS grew 33.3%, free cash flow fell 88.5% and total debt fell 79.8%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

9.83 0.69 −6.56%

Follow PBYI

Alert me

Market cap: $543.0M
P/E: 18.2×
Fwd P/E: 24.2×
Dividend yield: —
F-score: 8/9
Altman Z: −4.16
Beneish M: −2.06
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	7.08	9.44	12.78	15.02
P/S ratio Full definition →		1.26	1.30	1.43	1.79
P/FCF ratio Full definition →		8.80	10.18	7.92	14.46
P/Operating CF Full definition →		27.59	20.64	21.08	254.39
P/B ratio Full definition →		2.32	2.28	2.53	2.98
Price to Tangible BV Full definition →		3.74	3.35	3.63	4.05
EV/Sales Full definition →		1.02	1.01	1.07	1.48
EV/EBITDA Full definition →		4.82	4.80	6.05	8.34
EV/Operating CF Full definition →		5.01	5.53	4.54	8.30
EV/FCF Full definition →		7.09	7.91	5.93	11.95
Quick Ratio Full definition →		1.57	1.89	2.18	2.57
Current Ratio Full definition →		1.74	2.00	2.38	2.91
Net Debt/EBITDA Full definition →		(5.10)	(3.90)	74.24	(9.30)
Debt/Assets Full definition →		16.62%	10.41%	5.86%	0.00%
Debt/Equity Full definition →		0.29	0.17	0.09	0.00
Asset Turnover Full definition →		1.00	1.06	1.17	1.19
Operating CF/Net income Full definition →		1.10	1.07	(4.11)	0.20
Capex/Depreciation Full definition →		(0.01)	0.01	0.00	0.00
Interest Coverage Full definition →		6.43	15.29	(5.24)	42.14
Research and Development Expense of Revenue Full definition →		29.21%	22.32%	44.17%	33.44%
Selling, General and Administrative Expense of Revenue Full definition →		30.87%	24.36%	41.11%	31.06%
Intangible Assets out of Total Assets Full definition →		0.22	0.19	0.20	0.19
Share Based Compensation of Revenue Full definition →		3.07%	2.14%	4.23%	3.46%
Graham Net Nets Full definition →		0.21	0.26	0.24	0.22
Graham Number Full definition →		6.22	6.08	5.33	5.75
Earnings Yield Full definition →		14.12%	10.59%	7.82%	6.66%
Free Cash Flow Yield Full definition →		11.36%	9.82%	12.63%	6.92%
Revenue per Share Full definition →		1.08	1.51	0.88	1.11
Operating CF per Share Full definition →		0.19	0.29	0.30	0.03
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.19	0.29	0.30	0.03
Cash per Share Full definition →		1.92	1.99	2.04	1.84
Shareholders Equity per Share Full definition →		2.29	2.61	2.53	2.72
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		2.29	2.61	2.53	2.72
Free Cash Flow Full definition →		9.66	14.46	15.42	1.62
Working Capital Full definition →		60.85	81.43	82.52	95.25
Capital Expenditures Full definition →		(0.03)	0.04	—	—
Net Current Asset Value Full definition →		55.99	76.72	77.98	90.88
EV/EBIT Full definition →		6.42	6.20	8.26	11.22
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		7.97	7.98	11.02	13.57
Other line items
Average Receivables Full definition →		44.10	42.83	25.75	29.99
Average Payables Full definition →		6.95	5.28	7.10	4.26
Average Inventory Full definition →		6.07	7.12	8.72	10.96
Average Assets Full definition →		211.79	214.82	194.44	193.83
Average Common Equity Full definition →		93.18	111.23	112.76	121.63

Fold the line items

Columns are period end dates

Stockrow Weekly